Markets

Healthcare ETFs Are Latest Victim to Trump

Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug prices at a press conference. The healthcare sector was the worst performing area of the equities market on Wednesday, with the Health Care Select Sector SPDR (NYSEArca: XLV) down 1.3%. Meanwhile, biotech-related ETFs… Click to read more at ETFtrends.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article was provided by our partner Tom Lydon of etftrends.com.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

ETFs